![](https://fireflyfund.org/wp-content/uploads/2020/07/Podcast-Graphic-template-for-FF-Website_Episode-3.png)
Tune in for the second installation of Firefly Fund Co-Founders Pam & Chris Andrews’ conversation with Thomas Kirkegaard Jensen Ph.D., Co-Founder and Chief Scientific Officer and Kim Stratton, CEO of Orphazyme, a biopharmaceutical company that translates scientific discoveries into late-stage clinical development programs impacting lives of patients with orphan diseases and their families.